Your browser doesn't support javascript.
loading
Mismatched Imaging Findings of Prostate Cancer Diagnosis:68 Ga-PSMA PET/CT vs mpMRI / 대한핵의학회잡지
Article in En | WPRIM | ID: wpr-997531
Responsible library: WPRO
ABSTRACT
Multiparametric magnetic resonance imaging (mpMRI) is the modality of choice for initial diagnosis of prostate cancer (PCa), including biopsy-naïve patients. Nevertheless, clinicians must be aware of the possibility that up to one-fourth of clinically significant cancers might be missed by the modality. Acknowledgment of this occurrence and the increased availability of 68 Ga-PSMA PET/CT in clinical routine, open the door to new, fascinating, indications for this functional modality in the context of PCa detection. With the case herein illustrated, we report a paradigmatic example of mismatch findings between PET/CT and mpMRI better elucidating the potential indication.
Full text: 1 Database: WPRIM Language: En Journal: Korean Journal of Nuclear Medicine Year: 2021 Document type: Article
Full text: 1 Database: WPRIM Language: En Journal: Korean Journal of Nuclear Medicine Year: 2021 Document type: Article